Skip to main content
. 2018 May 17;9(7):691–696. doi: 10.1021/acsmedchemlett.8b00150

Figure 2.

Figure 2

Cocrystal structures of WT1a HCV NS3/4A protease in complex with linear inhibitors (a) 12b, (b) 12c, and (c) 12d. The protease active site is presented as a light gray surface with bound inhibitors depicted as orange sticks. The catalytic triad is highlighted in yellow, and drug resistance residues Arg155, Ala156, and Asp168 are shown as sticks.